Research
Title : | Disarib, a novel BCL2 inhibitor in cancer therapy |
Area of research : | Life Sciences & Biotechnology |
Focus area : | Cancer biology |
Principal Investigator : | Dr. Sathees C. Raghavan, Professor, Indian Institute of Science (IISc), Bengaluru |
Timeline Start Year : | 2018 |
Timeline End Year : | 2021 |
Contact info : | sathees@iisc.ac.in |
Details
Organizations involved
Implementing Agency : | Indian Institute of Science (IISc), Bengaluru, Karnataka 560012 Funding Agency :Department of Biotechnology (DBT), New Delhi | |